Acumen Pharmaceuticals Aktie

Acumen Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3CTP6 / ISIN: US00509G2093

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
15.07.2025 13:54:55

Acumen, JCR Pharma Join To Develop Oligomer-targeted Enhanced Brain Delivery Therapy For Alzheimers

(RTTNews) - Acumen Pharmaceuticals (ABOS) announced a collaboration, option and license agreement with JCR Pharmaceuticals to develop an oligomer-targeted Enhanced Brain Delivery therapy for Alzheimers disease. JCR is a global specialty pharmaceuticals company.

Acumen is currently investigating sabirnetug, its lead program, in ALTITUDE-AD, a Phase 2, multi-center, randomized, double-blind, placebo-controlled trial. The company plans to share topline results, including efficacy and safety data, in late 2026. Acumen said the combination of sabirnetug or additional, AO-selective antibodies with JCRs BBB-penetrating technology or J-Brain Cargo strengthens its portfolio of AO-targeted therapies.

JCR will receive an upfront payment and will be eligible for an additional option payment should Acumen exercise its exclusive option to develop up to two development candidates. JCR will also be eligible to receive future development, commercialization and sales milestone payments, as well as single digit percentage royalties on sales of any products that result from the collaboration.

For More Such Health News, visit rttnews.com.

Nachrichten zu Acumen Pharmaceuticals Inc Registered Shsmehr Nachrichten

Analysen zu Acumen Pharmaceuticals Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Acumen Pharmaceuticals Inc Registered Shs 1,73 -2,26% Acumen Pharmaceuticals Inc Registered Shs
JCR Pharmaceuticals Co LtdShs 642,00 -2,13% JCR Pharmaceuticals Co LtdShs